European Neuropsychopharmacology

Article	Citations
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA	394
11. ESTABLISHING THE MOLECULAR FOUNDATION OF BRAIN ANATOMY IN LIVING INDIVIDUALS	110
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER	102
T84. AN INVESTIGATION ON GENETIC MECHANISMS UNDER CLINICAL HETEROGENEITY IN SCHIZOPHRENIA	101
F41. AMBER: ANTIDEPRESSANT MEDICATIONS: BIOLOGY, EXPOSURE AND RESPONSE	97
T56. DIP2A, HIGHLY EXPRESSED GENE IN THE CEREBELLUM, IS ASSOCIATED WITH A WIDE RANGE OF PSYCHIATRIC SYMPTOMS (DELAYED SPEECH, AUTISM SPECTRUM DISORDER AND SPECIFIC LEARNING DISABILITIES)	82
T13. GENETIC ASSOCIATIONS OF ICD-DERIVED PSYCHIATRIC DIAGNOSES WITH SELF-REPORTED MENTAL HEALTH PHENOTYPES IN THE UK BIOBANK	73
F8. THE DEVELOPMENTAL LANDSCAPE OF NEUROPSYCHIATRIC GENOMICS IN AFRICA	71
T78. GENE-ENVIRONMENT INTERACTION STUDY ON THE CORRELATES FOR PSYCHOTIC EXPERIENCES IN THE UK BIOBANK	67
T100. CHILD SUBCORTICAL BRAIN VOLUMES: THE INTERACTION BETWEEN GENETIC RISK AND MATERNAL PSYCHOLOGICAL DISTRESS DURING PREGNANCY	64
F97. DIFFERENTIAL EXPRESSION OF MICRORNAS UPON IN VITRO LITHIUM AND VALPROATE EXPOSURE TO BIPOLAR DISORDER PATIENTS-DERIVED LCLS	63
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES	62
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS	62
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES	60
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS	59
2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS	54
T35. SHARED GENETIC LIABILITY FOR ALCOHOL CONSUMPTION, ALCOHOL PROBLEMS, AND SUICIDAL BEHAVIOR: EVALUATING THE ROLE OF IMPULSIVITY	51
T33. USING GENOMICS TO AID EARLY DIFFERENTIAL DIAGNOSIS BETWEEN BIPOLAR DISORDER AND MAJOR DEPRESSION	51
T67. ASSOCIATIONS BETWEEN METHYLATION AGE AND BRAIN AGE IN LATE ADOLESCENCE	50
T59. A GENOME-WIDE ASSOCIATION STUDY OF EATING DISORDER SYMPTOMS BASED ON THE SCOFF QUESTIONNAIRE	50
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)	46
6. DE NOVO MUTATIONS IN BIPOLAR DISORDER IMPLICATE GENES INVOLVED IN NEURODEVELOPMENT AND IMMUNITY	46
Society Calendar	45
P.0511 The role of sex steroids and serotonin brain dynamics in perinatal mental health	44
W101. EPIGENETIC PROFILES OF LATENT CLASSES FOR POLYSUBSTANCE USE DISORDER	43

HOW PARTICIPATING IN CAMH'S PHARMACOGENETICS IMPACT STUDY CHANGED MY LIFE	42
P.0320 Depression, anxiety, psychotic-like symptoms and addiction in adolescents and adults who do and do not use cannabis	40
P.0753 Pharmacotherapy, treatment satisfaction and funcional impact among fibromyalgia patients: characterization of a Portuguese sample	40
P.0325 Corneal endothelial morphology and thickness changes in children with attention-deficit hyperactivity disorder	38
P.0260 Optimising a human induced pluripotent stem cell system to model the effects of il-6 on early neurodevelopment	38
F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD	37
W64. FAMILY BASED ASSOCIATION AND LINKAGE ANALYSES OF FAMILIAL ADHD	36
P.0234 Optogenetic shift of mesolimbic dopamine to tonic pattern reduces reward-seeking behavior	33
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder	33
P.0426 Proof-of-concept study testing SOM3355 for the treatment of chorea symptoms in Huntington's disease	33
POLYGENIC RISK SCORES FOR PROBLEMATIC SUBSTANCE USE IN ADOLESCENTS: AN ENIGMA-ADDICTION STUDY	33
P.0632 The added value of cognitive behavioral therapy on quality of life in combination with pharmacotherapy in adults with ADHD	33
P.0663 Zebrafish model : study of KCNB1 in developmental and epileptic encephalopathies	31
P.0016 Concomitant drug abuse in patients on methadone maintenance treatment	31
P.0190 Epigenetic mechanisms underlying the stress-induced activation of serum/glucocorticoid regulated kinase 1	30
P.0235 Selectivity of taar1 partial agonist ro5263397 effects on drug- versus non-drug-related behaviors	30
8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION	29
P.0669 Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19–related trauma	29
P.0224 Dosing regimen overview of treatment-resistant depression patients treated with esketamine: eskale study interim analysis	27
DECOLONISATION OF PSYCHIATRIC GENETICS: PERSPECTIVES FROM AN ERSTWHILE “JEWEL IN THE CROWN” COLONY	27
P.0487 The impact of psychopathy, temperament and character dimensions of personality on crimınal recidivism in patients with schizophrenia	27
P.0735 Functional impacts function - beyond organic symptoms in autoimmune encephalitis	27
NOVEL LOCI AND TARGET GENES INFLUENCING FUNCTIONAL SEIZURES IDENTIFIED IN A MULTI-SITE GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS IN A SAMPLE OF 570,460 PATIENTS	25
GENETIC COUNSELING FOR PSYCHIATRIC CONDITIONS	24
P.0665 Reward processing differences between Obsessive-compulsive disorder and pathological gambling	24
P.0254 TRPC4/5 inhibition reverses both stress-induced excessive aversion processing and attenuated reward processing in mice	24
THE ASSOCIATION BETWEEN POLYGENIC RISK FOR SCHIZOPHRENIA AND BRAIN AGE IN A POPULATION-BASED SAMPLE OF YOUNG ADULTS: A RECALL-BY-GENOTYPE-BASED APPROACH	24
The association of CNR1 genetic variants with resting-state functional connectivity in youth bipolar disorder	24
P.0690 Transdifferentiation of human monocytes into neuronal-like cells in patients with depression	23
P.0705 Antidepressant response prediction by early response, prefrontal theta cordance in rapid-eye movement sleep and ABCB1 genotype	23
P.0697 Exposure to an enriched environment shortens the onset of venlafaxine response which correlate with the remodeling of hippocampal parvalbumin interneurons	22
P.0323 History of abuse and post traumatic stress disorder in patients admitted to an addictive disorders day hospital	22
P.0675 Inhibitory control in therapy resistant patients with major depressive disorder	22
P.0262 Self-directed virtual care: a review of the evidence for current digital therapeutic methods in adult mental health patients	22
T8. TREATMENT WITH GALANTAMINE IN 15Q13.3 DELETIONS: GENOMICALLY-INFORMED PRECISION MEDICINE STRATEGIES IN NEURODEVELOPMENTAL DISORDERS	21
DO POOR DIET AND LIFESTYLE BEHAVIOURS EXACERBATE THE GENETIC RISK OF IMPULSIVITY IN THE GENERAL POPULATION	21
PUMAS: POPULATIONS UNDERREPRESENTED IN MENTAL ILLNESS ASSOCIATION STUDIES PROJECT	21
Editorial Board	21
W87. RARE, PATHOGENIC COPY NUMBER VARIANTS CO-SEGREGATE WITH SCHIZOPHRENIA IN PEDIGREE COHORT	20
T121. MULTI-OMIC NETWORK ANALYSIS IDENTIFIES KEY NEUROBIOLOGICAL PATHWAYS IN OPIOID ADDICTION	20
F94. SIGNIFICANT TELOMERE SHORTENING IN MALAYSIAN PATIENTS WITH SCHIZOPHRENIA: RELATIONSHIP WITH TOTAL ANTIOXIDANT CAPACITY AND OTHER COVARIATES	20
T70. A COMPUTATIONAL TRANSCRIPTOMICS APPROACH TO DRUG REPURPOSING IDENTIFIES NEW THERAPEUTIC CANDIDATES FOR TREATMENT OF CHRONIC PAIN	19
ECNP Calendar of Meetings	19
DIFFERENTIAL ISOFORM USAGE IN SCHIZOPHRENIA	19
25. EPIGENOME-WIDE META-ANALYSIS OF > 3200 MILITARY AND CIVILIAN PARTICIPANTS IDENTIFIES CELL-TYPE SPECIFIC DNA METHYLATION SIGNALS ASSOCIATED WITH PTSD	19
P.0564 Active suicidal ideation one year after the beginning of COVID-19 pandemic in a large spanish sample: risk and protective factors	19
P.0012 The costs of alcohol hangover for the Dutch economy: impact of absenteeism and presenteeism	19
P.0565 Calcium salt of N-(5-hydroxynicotinoyl)-L-glutamic acid weakens depressive-like behavior and Parkinsonian syndrome in experiment on rodents	19
Editorial Board	18
37. CONVERGENT IMPACT OF SCHIZOPHRENIA RISK GENES	18

Opioid use and misuse in Europe: COVID-19 new challenges?	18
BEYOND STANDARD GWAS IN BIPOLAR DISORDER: INTEGRATIVE FINE-MAPPING, MULTI-TRAIT, AND EPIGENETIC APPROACHES FOR CAUSAL VARIANT DISCOVERY	17
Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats	17
Muscle and the mind: The combination of creatine and exercise for depression	17
M70. INTRODUCTION TO THE MOUNT SINAI MILLION SCHIZOPHRENIA DISCOVERIES PROGRAM (MSM-SCZ)	17
Norepinephrine system dysconnectivity in major depressive disorder: the effect of short term SSRI treatment	17
W2. MULTIVARIABLE GENE ENVIRONMENT INTERACTION IN THE PREDICTION OF PROSOCIAL BEHAVIOR	17
T39. POLYGENIC RISK AND CHILDHOOD TRAUMA AS PREDICTORS OF SUICIDE RISK IN BIPOLAR DISORDER	17
A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder	17
3. MODELING AGE-DEPENDENT GENETIC EFFECTS ON TEMPERAMENT AND MENTAL HEALTH	16
W87. PREDICTORS OF ALCOHOL CONSUMPTION: THE ROLE OF GENETICS AND IMPULSIVITY FROM ADOLESCENCE TO ADULTHOOD	16
ELECTRONIC HEALTH RECORDS AND BIOBANKS IN THE ERA OF COMPUTATIONAL AND GENOMIC PSYCHIATRY	16
M74. RE-EVALUATING THE ROLE OF 22Q11 DELETION SYNDROME (22Q11DS) IN SCHIZOPHRENIA	16
T33. MULTI-OMICS MACHINE LEARNING APPROACHES TO ELUCIDATE BIOLOGICAL SIGNATURES OF DEPRESSION: INSIGHTS FROM THE UK BIOBANK	16
17. LANDSCAPE SURVEY OF 8853 CLINICAL TRIALS IN DEPRESSION TO IDENTIFY NEW TREATMENT RESPONSE PHARMACOGENETIC STUDIES	16
W17. CONCORDANT AND DISCORDANT GENETIC VARIANTS ASSOCIATED WITH MENTAL ILL-HEALTH AND THEIR IMPACT ON CARDIOMETABOLIC RISK	15
87. ATLAS OF PHENOTYPE-GENOTYPE RELATIONSHIPS BETWEEN PLASMA METABOLIC MARKERS, BRAIN MORPHOLOGY AND PSYCHIATRIC DISORDERS	15
W47. THE GENETIC ARCHITECTURE OF DIFFICULT-TO-TREAT DEPRESSION: A PHARMLINES INITIATIVE COHORT STUDY	15
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review	15
P.0247 Assessment of sexual behavior of taar2 and taar5 knockout mice	14
Exploring the link between functional connectivity of ventral tegmental area and physical fitness in schizophrenia and healthy controls	14
Editorial Board	14
T3. DEPRESSION ASSOCIATED GENETIC, TRANSCRIPTOMIC AND PATHWAY -LEVEL PROFILING OF TRAUMA-EXPOSED MILITARY AND CIVILIAN COHORTS	14
The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders	14
Stress, mental disorder and ketamine as a novel, rapid acting treatment	14
W31. KETAMINE AND ELECTROCONVULSIVE THERAPY DEPRESSION TREATMENTS ALTER ISOFORM- AND CELL TYPE-SPECIFIC TRANSCRIPTOMES IN THE MOUSE PREFRONTAL FRONTAL CORTEX	14
Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders	14
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial	14
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder	14
Editorial Board	14
W38. INVESTIGATION OF GENE-ENVIRONMENT INTERACTIONS BETWEEN GENETICALLY REGULATED GLUCOCORTICOID REACTIVITY AND STRESSFUL LIFE EVENTS IN MAJOR DEPRESSIVE DISORDER	14
T71. GENETIC AND ENVIRONMENTAL ASSOCIATION BETWEEN PRESENT MOMENT ATTENTION AND SUBJECTIVE WELLBEING	13
F10. TRACES OF ASSORTATIVE MATING FOR MENTAL DISORDERS IN THE HUMAN GENOME	13
LONGITUDINAL GENETIC APPROACHES IN MENTAL HEALTH: INTERNATIONAL PERSPECTIVES AND OPPORTUNITIES	13
F11. PATTERNS OF GENETIC OVERLAP BETWEEN BIPOLAR DISORDER, SUBSTANCE USE DISORDERS AND SUBSTANCE CONSUMPTION PHENOTYPES REVEAL DISTINCT FACTORS OF PATHOLOGY	13
W17. REGIONAL GENETIC ARCHITECTURE OF THE CORPUS CALLOSUM AND ITS OVERLAP WITH PSYCHIATRIC AND SUBSTANCE USE PHENOTYPES	13
F59. DISENTANGLING THE OVERLAP BETWEEN SUICIDE ATTEMPT AND ASSOCIATED PHENOTYPES USING LOCAL GENETIC CORRELATIONS	13
T75. ASSOCIATIONS BETWEEN POLYGENIC RISK SCORE FOR SCHIZOPHRENIA AND SCHIZOTYPAL TRAITS IN THE MULTIPLEX FAMILIES OF PATIENTS WITH SCHIZOPHRENIA	13
F99. GENETIC CORRELATION OF CHILDHOOD AGGRESSION WITH MENTAL AND GENERAL HEALTH TRAITS	13
ABSENCE OF NONFATAL SUICIDAL BEHAVIOR PRECEDING SUICIDE DEATH REVEALS CLINICAL AND GENETIC RISK DIFFERENCES	13
W32. A GENOME-WIDE ASSOCIATION STUDY OF BIPOLAR DISORDER FROM INDIA	12
PRS PREDICTION BEYOND FAMILY HISTORY	12
TREML2 IN THE CONTEXT OF WHITE MATTER HYPERINTENSITIES AND ALZHEIMER'S DISEASE	12
87. RS148582811 REGULATES ITS HOST GENE ARVCF EXPRESSION TO AFFECT NICOTINE-ASSOCIATED HIPPOCAMPUS-DEPENDENT MEMORY	12
46. PATHWAY-BASED POLYGENIC RISK SCORES USING MACHINE LEARNING: APPLICATION TO SCHIZOPHRENIA AND BIPOLAR DISORDER	12
MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDIES PROVIDE NOVEL BIOLOGICAL INSIGHTS INTO THE GENETIC ARCHITECTURE OF BIPOLAR DISORDER	12
54. EXAMINING COMMON AND SPECIFIC GENETIC INFLUENCES ON SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION	12
INNOVATING KNOWLEDGE DISSEMINATION FOR CULTURAL RELEVANCE AND ACCESSIBILITY	12
W9. IDENTIFYING CENTRAL AND TRANS-DIAGNOSTIC PSYCHIATRIC SYMPTOMS COMBINING NETWORK ANALYSIS AND GENETICS	12
20. PHENOME-WIDE ASSOCIATION STUDY OF COGNITIVE FUNCTION IN MULTIETHNIC ASIAN POPULATION	12
PRESENTING A MULTIDISCIPLINARY FRAMEWORK FOR RESEARCH GENOME SEQUENCING COUPLED WITH GENETIC COUNSELING AND RETURN OF CLINICALLY VALIDATED PRIMARY AND SECONDARY FINDINGS FOR INDIVIDUALS WITH PSYCHIATR	12
75. GWAS IDENTIFIES NOVEL LOCI ASSOCIATED WITH SPECIFIERS OF BIPOLAR DISORDER	12
WHOLE EXOME SEQUENCING IN AN AUTISM MULTIPLEX FAMILY OF INDIAN ORIGIN REVEALS INCREASED GENETIC BURDEN OF MATERNALLY TRANSMITTED VARIANTS	11
Psychopathology for the twenty-first century: Towards a ChatGPT psychopathology?	11
M45. OPEN BOARD	11
A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood	11
Prader Willi syndrome, its psychiatric implications and their possible biological basis	11
Letter to editor about the article “Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis” (De Prisco M et al.,2023)	11
SLEEP INERTIA DRIVES THE ASSOCIATION OF EVENING CHRONOTYPE WITH PSYCHIATRIC DISORDERS: GENETIC AND EPIDEMIOLOGICAL EVIDENCE	11
M25. POLYGENIC RISKS AND CARDIOVASCULAR TREATMENT EFFECTS IN SEVERE MENTAL ILLNESS	11
T68. DDR1 PROMOTER METHYLATION IN DIFFERENT PSYCHIATRIC DISORDERS AND ITS RELATIONSHIP TO NEUTROPHIL-TO-LYMPHOCYTE RATIOS	11
DECODING CELL TYPE-SPECIFICITY THROUGH SYSTEMATIC CELL TYPE ANNOTATIONS OF SINGLE-CELL RNA SEQUENCING DATA AMONG TISSUES AND APPLICATION TO PSYCHIATRIC DISORDERS AND OTHER TRAITS	11
Letter to the editor concerning: “Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis”	11
W12. BIDIRECTIONAL CROSS-TRAIT GENETIC NURTURE BETWEEN INTERNALIZING AND SUBSTANCE USE DOMAINS	11
INSIGHTS INTO THE METABOLIC ORIGINS OF ANOREXIA NERVOSA THROUGH GENOMICS AND NEUROIMAGING	10
16. HOW DO PATIENTS WITH MAJOR DEPRESSION RESPOND TO DOSAGE INCREMENTS OF ANTIDEPRESSANTS? A CLINICAL AND GENETIC INVESTIGATION IN UK BIOBANK	10
W88. GENETICALLY FASTER CYP2A6-MEDIATED NICOTINE METABOLISM INCREASES SMOKING-RELATED DISEASE RISK: A PHENOME-WIDE ASSOCIATION STUDY IN THE ALL OF US RESEARCH PROGRAM	10
Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.	10
P.0747 The CD45+ blood cells alpha-synuclein concentration in synucleinopathies	10
T62. EXPLORING THE LANDSCAPE OF GENETIC TESTING FOR AUTISM: PERSPECTIVES FROM AUTISTIC INDIVIDUALS, FAMILIES, AND PHYSICIANS AND TRENDS IN HEALTHCARE DATA IN ALBERTA, CANADA	10
M21. POLYGENICITY OF ANOREXIA NERVOSA AT THE PATHWAY LEVEL	10
W1. CAN RESPONSE TO PSYCHOTHERAPY IN OBSESSIVE-COMPULSIVE DISORDER BE PREDICTED FROM DNA METHYLATION DATA?	10
W66. NEUROBIOLOGICAL CORRELATES OF MALE SEXUAL ORIENTATION	10
BEYOND BORDERS: INTEGRATING TRAINING AND RESEARCH FOR SCIENTIFIC EXCELLENCE AND GLOBAL EQUITY	10
EXOME SEQUENCING TECHNOLOGY AND ANALYSIS	10
W54. DETECTION OF DIFFERENTIALLY EXPRESSED GENES IN IPSC-DERIVED TROPHOBLAST CULTURES FROM CONTROLS AND PATIENTS WITH SCHIZOPHRENIA	10
POPULATION MEDICAL GENOMICS IN LATIN AMERICA	10
AN INTERNATIONAL, CASE-CASE META-ANALYSIS OF TREATMENT RESISTANT SCHIZOPHRENIA VERSUS NON-TREATMENT RESISTANT SCHIZOPHRENIA	10
THE ROLE OF SEX IN POLYGENIC RISK FOR SEX-BIASED BRAIN DISORDERS	10
Social Stress in Bipolar Disorder	10

ASSESSING THE UTILITY OF PHARMACOGENETIC TESTING IN A COHORT WITH TREATMENT-RESISTANT SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER	10
GENOMIC STRUCTURAL EQUATION MODELING APPLIED TO 14 MAJOR PSYCHIATRIC DISORDERS	9
P.0528 Long-acting antipsychotic injectables in patients under compulsory outpatient treatment: the right to choose	9
P.0126 Involvement of the snare complex SNAP-25 and stx1a polymorphisms in sarcopenia	9
W35. INVESTIGATION OF RELATIONSHIPS BETWEEN INTERNALIZING, EXTERNALIZING, AND RISKY SEXUAL BEHAVIOR: A GENETICALLY-INFORMATIVE SAMPLE	9
P.0059 Self-reported suicide attempts in the general population and association with alcohol consumption in Latvia in 2010-2018	9
T95. ITERATING TOWARDS PRECISION PHENOTYPING OF SCHIZOPHRENIA IN THE ELECTRONIC HEALTH RECORD	9
F3. METABOLIC EFFECT OF CYP2C19 AND CYP2D6 ON ANTIDEPRESSANT RESPONSE: A META-ANALYSIS OF 13 DEPRESSION PHARMACOGENETIC STUDIES	9
P.0522 Accessing electroconvulsive therapy: description and factors associated with variation of utilization in france in 2019	9
POLYGENIC SCORE OF POST-TRAUMATIC STRESS DISORDER HIGHLIGHTS ASSOCIATION WITH CARDIOVASCULAR DISORDERS IN ELECTRONIC HEALTH RECORDS OF >94,000 INDIVIDUALS	9
Number needed to treat and number needed to harm: What are they good for?	9
W14. EXPLORING THE RELATIONSHIP BETWEEN GENETIC PREDISPOSITION TO MENTAL HEALTH DISORDERS AND THE SOCIAL ENVIRONMENT IN THE UK BIOBANK	9
86. AN INTERNATIONAL, CASE-CASE MEGA-ANALYSIS OF TREATMENT-RESISTANT SCHIZOPHRENIA VERSUS NON-TREATMENT RESISTANT SCHIZOPHRENIA	9
Serotonin 5-HT2A receptors in schizophrenia: Reflexions on an unfinished story	9
T23. ASSOCIATION OF CHILDHOOD TRAUMA EXPOSURE WITH DDR1 PROMOTER METHYLATION IN BIPOLAR DISORDER	9
P.0062 Role of stress history in the development of a depressive-like phenotype in elderly in rats exposed to repeated social defeat	9
Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence	9
P.0112 Evaluation of circadian rhythm parameters and NR1D1 single nucleotide polymorphism relationship to predict lithium response in bipolar disorder	9
ECNP Calendar of Meetings	9
32. PRINCIPAL AND INDEPENDENT GENOMIC COMPONENTS OF BRAIN STRUCTURE AND FUNCTION: ROBUSTNESS AND RELEVANCE	9
W6. INTERACTION BETWEEN BDNF METHYLATION, SUICIDAL IDEATION, AND LONG-TERM OUTCOMES AFTER STROKE	9
W44. UNVEILING GENETIC ARCHITECTURES FOR STRATIFYING TRAJECTORIES OF ADOLESCENT DEPRESSION	8
P.0172 Deciphering the role of MIR-137 targetome in schizophrenia: temporal profiling and comorbidity with psychiatric disorders	8
P.0182 Cytomegalovirus infection and IQ in adolescents with early-onset psychosis	8
P.0438 Saccadik eye movements in simple and complex visual environments differenciate mild cognitive impairment: preliminary clinical results	8
Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years	8
T65. GENES IN POSTMORTEM BRAIN TISSUE DIFFERENTIALLY EXPRESSED IN CHRONIC PAIN	8
P.0278 Structural brain abnormalities associated with cognitive impairments in bipolar disorder	8
73. IMPACT OF GENETIC RISK VARIANTS OF MENTAL DISORDERS ON EPIGENETIC REGULATION: AN MQTL APPROACH	8
Corrigendum to “Modelling decision-making under uncertainty: A direct comparison study between human and mouse gambling data” [31, February 2020, Pages  58–68]	8
Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials	8
P.0358 Synergistic anticonvulsant effect of carbamazepine and mono-/bicyclic terpenoids on pentylenetetrazole-induced seizures	8
P.0374 Use of cariprazine in first episode mania: the importance of the treat and the treatment	8
P.0075 Sex differences in anxiolytic and antidepressant response following subacute drug treatment: the effect of the oestrous cycle	8
P.0364 Neurocognitive profiles of bipolar disorder patients receiving olanzapine or quetiapine in addition to mood-stabilizers	8
P.0477 Antipsychotic treatment and risk of discontinuation of cardiometabolic drugs in schizophrenia	8
P.0713 Effectiveness and safety of vortioxetine in real-world clinical practice in China: results from the prospective RELIEVE China study	8
W97. A GENOMEWIDE ASSOCIATION STUDY OF ANTIPSYCHOTIC INDUCED EXTRAPYRAMIDAL SIDE EFFECTS	8
PHARMACOGENETICS OF ANXIETY AND OBSESSIVE-COMPULSIVE DISORDERS	8
P.0631 Functional connectivity of basal ganglia nuclei in ADHD and pharmacologically challenged healthy volunteers with a genetic risk profile	8
Pediatric Bipolar Disorder – Misinformation with Unintended Negative Consequences for Children and Adolescents	8
P.0365 Associations between abnormal brain function during emotion processing and lifetime disease course in major depressive disorder	8
P.0673 Specificity of neurocognitive impairment in patients with schizophrenia and endogenous depression	8
EVALUATING THE CAUSAL RELATIONSHIP BETWEEN EDUCATIONAL ATTAINMENT AND MENTAL HEALTH	8
P.0393 Interoception sensitivity and social ineraction in major depressive episode	8
P.0798 Acute peritraumatic distress predicts post-traumatic stress disorder at 6 months in patients with bipolar disorder followed during the COVID-19 pandemic	8
As in cooking, so in medicine: Doses do matter	8
Cell type-specific methylome-wide association studies of childhood ADHD symptoms	7
Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up	7
GENOME-WIDE ASSOCIATION STUDIES OF ANOREXIA NERVOSA: AN OVERVIEW, UPDATE, AND IMPLICATIONS	7
F80. A DNA METHYLATION STUDY OF COMMON AND SPECIFIC TREATMENT EFFECTS OF THREE ANTIPSYCHOTICS IN THE TREATMENT OF PSYCHOSIS	7
T85. INVESTIGATING THE GENETIC ARCHITECTURE OF REGIONAL BRAIN STRUCTURE AND ITS RELATIONSHIP TO SCHIZOPHRENIA	7
T28. EXPLORING THE RELATIONSHIP BETWEEN ACNE AND MENTAL HEALTH DISORDERS	7
AN ONTOLOGICAL BASED APPROACH TO CHARACTERIZE THE BEHAVIORAL DIFFERENCES BETWEEN PATIENTS WITH 16P11.2 DUPLICATION AND DELETION	7
94. AN INDUCED PLURIPOTENT STEM CELL (IPSC) RESOURCE FROM GENETICALLY ISOLATED FAMILIES WITH NEUROPSYCHIATRIC DISORDERS	7
Disease continuum centered on Parkinson's disease	7
Exploring the incidence of inadequate response to antidepressants in the primary care of depression	7
F93. CELL-TYPE SPECIFIC TRANSCRIPTOMIC PROFILING IN SCHIZOPHRENIA IDENTIFIES CHANGES IN GABAERGIC NEURONS AND OLIGODENDROCYTES AT TRANSCRIPT LEVEL	7
PERCEPTIONS OF CAUSAL ATTRIBUTION AND ATTITUDES TO GENETIC TESTING AMONG PEOPLE WITH SCHIZOPHRENIA AND THEIR FIRST-DEGREE RELATIVES	7
P.0600 Evaluation of real clinical experience in outpatients with psychosis who undergo monthly and quarterly paliperidone palmitate treatments	7
F39. CONTRIBUTION OF COMMON POLYGENIC VARIATION TO THERAPY RESPONSE IN THE EARLY MEDICATION CHANGE COHORT	7
HOW DO WE MAKE POLYGENIC RISK SCORES (PRS) UNDERSTANDABLE? THE DEVELOPMENT AND EVALUATION OF A NEW TOOL TO ACCOMPANY PRS	7
41. USING BRAIN CELL-TYPE-SPECIFIC INTERACTOMES OF PROTEINS ENCODED BY RISK GENES TO UNCOVER BIOLOGY UNDERLYING SCHIZOPHRENIA AND RELATED DISORDERS	7
Predicting 10-year risk of chronic kidney disease in lithium-treated patients with bipolar disorder: A risk model development and internal cross-validation study	7
Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls	7
Antidepressant use in pregnancy and neonatal outcomes: reassuring findings from an asian cohort	7
GENOME-WIDE GENE-GENE INTERACTION OF THE 5-HTTLPR PROMOTER POLYMORPHISM EMPHASIZES THE IMPORTANT ROLE OF NEUROPLASTICITY IN DEPRESSION	7
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD coh	7
F59. DISSECTING THE CONTRIBUTIONS OF RARE AND COMMON GENETIC VARIATION TO NEURODEVELOPMENTAL OUTCOMES	7
F44. DIFFERENCES IN POLYGENIC RISK SCORE FOR MAJOR DEPRESSIVE DISORDER DEPENDING ON CASE DEFINITION IN AN ELECTRONIC HEALTH RECORDS STUDY	7
T54. FIRST GWAS ON AFFECTIVE TEMPERAMENTS IDENTIFIES NOVEL GENOME-WIDE SIGNIFICANT VARIANT FOR ANXIOUS TEMPERAMENT AND SUGGESTIVE VARIANTS FOR ALL FIVE AFFECTIVE TEMPERAMENTS	7
13. DISTINGUISHING DIFFERENT PSYCHIATRIC DISORDERS USING DDX-PRS	7
Associations between individual depressive symptoms and immunometabolic characteristics in major depression	7
The genetics of treatment-resistant depression: controversies and perspectives	7
Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trial	7
CONTRIBUTION OF GENOME SEQUENCING IN THE EVALUATION OF CHILDREN AND ADOLESCENTS WITH SUSPECTED SERONEGATIVE AUTOIMMUNE ENCEPHALITIS	6
26. UNRAVELING THE HETEROGENEITY OF PTSD SYMPTOMS THROUGH IDENTIFYING EPIGENETIC SUBTYPES AMONG TRAUMA-EXPOSED CIVILIAN WOMEN	6
FINE-MAPPING ACROSS DIVERSE ANCESTRIES DRIVES THE DISCOVERY OF PUTATIVE CAUSAL VARIANTS UNDERLYING HUMAN COMPLEX TRAITS AND DISEASES	6
P.0227 Integrated care with pharmacists in monitoring of ambulatory patients using lithium	6
Neuroscience-based nomenclature of psychotropics: Progress report	6
P.0308 Safety and efficacy of alcohol hangover treatments	6
How else can inflammation kill you?	6
CHARACTERIZING THE LOCAL GENETIC CORRELATIONS BETWEEN 14 MAJOR PSYCHIATRIC DISORDERS	6
P.0114 Complement factor C4 and phenotypes in bipolar disorder	6
T82. ASSOCIATION OF SCHIZOPHRENIA POLYGENIC RISK SCORES WITH TREATMENT-RESISTANT SCHIZOPHRENIA	6
THE GENETIC ARCHITECTURE OF BEAT SYNCHRONIZATION THROUGH A NEURODEVELOPMENTAL AND NEURO-FUNCTIONAL LENS	6
P.0428 Alpha-synuclein alters expression levels of immediate early genes in Parkinson's disease associated with mutations in the GBA gene	6
P.0251 Influence of the a2a antagonist kw6002 on dopaminergic system, motor functioning and neuroinflammation in a rodent model of parkinson's disease	6
VARIANCE QUANTITATIVE TRAIT LOCI MAPPING IN THE MOBA COHORT: DETECTING INTERACTION EFFECTS INVOLVED IN DEVELOPMENTAL OUTCOMES	6
THE IMPACT OF EARLY ADVERSITY AND EDUCATIONAL ATTAINMENT ON GENETIC AND BRAIN MORPHOLOGICAL PREDICTORS OF INTELLIGENCE	6
57. TRANSCRIPTOMIC DYSFUNCTION DISPARITIES: GREATER BURDEN IN FEMALE BRAINS HIGHLIGHTS IMMUNE AND SYNAPTIC PATHWAYS FOR PSYCHIATRIC DISORDERS	6
I WOULDN'T TREAT A [POLYGENIC RISK] SCORE WITH PILLS	6
P.0225 Indirect comparison estimating the benefit of esketamine compared to real-world treatment of treatment resistant depression in general psychiatry: preliminary analysis	6
P.0634 A pilot randomized control trial with the probiotic strain Lactobacillus rhamnosus GG (LGG) in children and adolescents with ADHD	6
F57. INVESTIGATION OF THE SEX CHROMOSOMES IN AUTISM SPECTRUM DISORDER	6